Delivery Order SPE2DB22D2206-SPE2DB25FDW94

Award Date 10/22/24
Potential Completion Date 10/23/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 4567765785 ! KETAMINE 500 MG/10 ML VIAL 10ML. The contract is a Delivery Order with a Firm Fixed Price of $1,311.56 and an ultimate completion date of April 2, 2025. The award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,346.00 firm fixed-price delivery order is for the procurement of 4567475769 - KETAMINE 500 MG/5 ML VIAL 5ML. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is a delivery order (SPE2DB20D2014|SPE2DB25FB94M) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,235,218 units of 200 mg/20 ml ketamine vials. The $1,773.46 firm fixed-price contract has a completion date of May 14, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the supply of 500 mg/5 ml Ketamine vials, a pharmaceutical product used for medical purposes. The contract has a firm fixed price of $1,664.37 and a completion date of May 13, 2025. This delivery order is part of a larger Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,210.38, is for the delivery of Ketamine 200 mg/20 ml vials. The contract is a firm fixed-price delivery order with a completion date of January 14, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,059 firm-fixed-price delivery order is for the supply of 4,566,134,691 units of Ketamine 500 mg/5 ml vials. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4566631897 - Ketamine 200 mg/20 ml vials. The $3,595.73 firm fixed-price delivery order has a completion date of December 9, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,650.06 fixed-price delivery order is for the supply of 200 mg/20 mL vials of the medication ketamine. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,759.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4554379185 - Ketamine 500 mg/5 ml vial, 5 ml, with an ultimate completion date of August 11, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the procurement of Ketamine 200 mg/20 ml vials. The contract has a firm fixed price, with a ceiling value of $5,561.85, and a period of performance through February 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDW94
    Delivery Order

This federal contract award, valued at $1,059.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566177375 - KETAMINE 500 MG/5 ML VIAL 5ML and has an ultimate completion date of October 23, 2024.

The award is a Delivery Order placed under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 1/22/25, 12:57 AM